India’s aesthetic injectables market set for 5% CAGR surge by 2030: Report

The Indian aesthetic injectables market is projected to experience substantial growth, estimated at over 5 per cent CAGR by 2030, a recent report reveals. This surge aligns with an increased trend of beauty consciousness among the populace, propelling the demand for cosmetic procedures and related products across the country. Attributed to a report by GlobalData, this remarkable upswing is primarily spurred by amplified awareness about diverse beauty treatments coupled with the pervasive influence of social media on beauty standards. As of 2023, India represents approximately 1 per cent of the Asia-Pacific (APAC) aesthetic injectables market in terms of revenue.

The rising preference for non-surgical and non-invasive aesthetic injectables, such as botulinum toxin, hyaluronic, and non-hyaluronic acid fillers, is significantly contributing to this market surge. These injectables ensure efficacy, safety, and quicker recovery periods, aligning with modernday preferences. The pandemic has impacted consumer behaviour, increasing their desire for more rejuvenated, hydrated, and plumper skin, sans invasive surgical procedures. There has also been a shift in consumer behaviour, with individuals willing to invest a portion of their disposable income in aesthetic enhancements, thereby boosting market growth. Moreover, the proliferation of injectable fillers in the market is expanding the options available to consumers and practitioners. The use of advanced technologies like virtual reality and artificial intelligence for personalised skin-type recommendations and post-procedure monitoring is catering to a wider customer base.